Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Shumin Pan

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
Zhonghua Fu Chan Ke Za Zhi|August 14, 2015
[Effect of S100 calcium binding protein A12 on the pathogenesis of preeclampsia]Xianlan Zhao, Shumin Pan, Cai Liu
Applied Optics|June 10, 2024
High precision 3 × 3 coupler demodulation algorithm with an additional phase shift judgment moduleShumin Pan, Qiang Ge, Gang Zhang, et al.
International Immunopharmacology|September 19, 2023
EuHD1 protects against inflammatory injury driven by NLRP3 inflammasomeHuanhuan Qiu, Wei Wang, Kejun Hu, et al.
Basic & Clinical Pharmacology & Toxicology|December 30, 2022
Bortezomib inhibits hepatocellular carcinoma via the Hippo-Yes-associated protein signalling pathwayYu Liao, Kejun Hu, Wangwang Liu, et al.
British Journal of Haematology|September 25, 2021
Iron parameters in pregnant women with beta-thalassaemia minor combined with iron deficiency anaemia compared to pregnant women with iron deficiency anaemia alone demonstrate the safety of iron supplementation in beta-thalassaemia minor during pregnancyNiankun Chen, Zhongjun Li, Yingying Huang, et al.
European Journal of Pharmacology|September 13, 2022
M378 exhibits anti-inflammatory activities through NLRP3 signaling pathwayJinling Xu, Qi Lv, Shumin Pan, et al.
Molecular Pharmacology|February 26, 2026
Cepharanthine, a valuable sanative alternative for hepatocellular carcinoma through regulating Hippo-Yes-associated protein signal transductionKejun Hu, Yukai Zhao, Xinyu Fu, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|January 12, 2026
USP9X as a Candidate Mediator of Prenatal Aspirin-Induced Ovarian Reserve Reduction in Offspring MiceYating Li, Caiyun Ge, Wai Yen Yim, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Zhonghua Fu Chan Ke Za Zhi|August 14, 2015
[Effect of S100 calcium binding protein A12 on the pathogenesis of preeclampsia]Xianlan Zhao, Shumin Pan, Cai Liu
Applied Optics|June 10, 2024
High precision 3 × 3 coupler demodulation algorithm with an additional phase shift judgment moduleShumin Pan, Qiang Ge, Gang Zhang, et al.
International Immunopharmacology|September 19, 2023
EuHD1 protects against inflammatory injury driven by NLRP3 inflammasomeHuanhuan Qiu, Wei Wang, Kejun Hu, et al.
Basic & Clinical Pharmacology & Toxicology|December 30, 2022
Bortezomib inhibits hepatocellular carcinoma via the Hippo-Yes-associated protein signalling pathwayYu Liao, Kejun Hu, Wangwang Liu, et al.
British Journal of Haematology|September 25, 2021
Iron parameters in pregnant women with beta-thalassaemia minor combined with iron deficiency anaemia compared to pregnant women with iron deficiency anaemia alone demonstrate the safety of iron supplementation in beta-thalassaemia minor during pregnancyNiankun Chen, Zhongjun Li, Yingying Huang, et al.
European Journal of Pharmacology|September 13, 2022
M378 exhibits anti-inflammatory activities through NLRP3 signaling pathwayJinling Xu, Qi Lv, Shumin Pan, et al.
Molecular Pharmacology|February 26, 2026
Cepharanthine, a valuable sanative alternative for hepatocellular carcinoma through regulating Hippo-Yes-associated protein signal transductionKejun Hu, Yukai Zhao, Xinyu Fu, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|January 12, 2026
USP9X as a Candidate Mediator of Prenatal Aspirin-Induced Ovarian Reserve Reduction in Offspring MiceYating Li, Caiyun Ge, Wai Yen Yim, et al.
Pageof 1